235 related articles for article (PubMed ID: 24978295)
21. Identification and characterization of novel protein-derived arginine-rich cell-penetrating peptides.
Gautam A; Sharma M; Vir P; Chaudhary K; Kapoor P; Kumar R; Nath SK; Raghava GP
Eur J Pharm Biopharm; 2015 Jan; 89():93-106. PubMed ID: 25459448
[TBL] [Abstract][Full Text] [Related]
22. Macrocyclic cell penetrating peptides: a study of structure-penetration properties.
Traboulsi H; Larkin H; Bonin MA; Volkov L; Lavoie CL; Marsault É
Bioconjug Chem; 2015 Mar; 26(3):405-11. PubMed ID: 25654426
[TBL] [Abstract][Full Text] [Related]
23. Cell-Surface Interactions on Arginine-Rich Cell-Penetrating Peptides Allow for Multiplex Modes of Internalization.
Futaki S; Nakase I
Acc Chem Res; 2017 Oct; 50(10):2449-2456. PubMed ID: 28910080
[TBL] [Abstract][Full Text] [Related]
24. Methodological and cellular aspects that govern the internalization mechanisms of arginine-rich cell-penetrating peptides.
Nakase I; Takeuchi T; Tanaka G; Futaki S
Adv Drug Deliv Rev; 2008 Mar; 60(4-5):598-607. PubMed ID: 18045727
[TBL] [Abstract][Full Text] [Related]
25. Fatty acyl moieties: improving Pro-rich peptide uptake inside HeLa cells.
Fernández-Carneado J; Kogan MJ; Van Mau N; Pujals S; López-Iglesias C; Heitz F; Giralt E
J Pept Res; 2005 Jun; 65(6):580-90. PubMed ID: 15885117
[TBL] [Abstract][Full Text] [Related]
26. Cell-penetrating properties of the transactivator of transcription and polyarginine (R9) peptides, their conjugative effect on nanoparticles and the prospect of conjugation with arsenic trioxide.
Kanwar JR; Gibbons J; Verma AK; Kanwar RK
Anticancer Drugs; 2012 Jun; 23(5):471-82. PubMed ID: 22241171
[TBL] [Abstract][Full Text] [Related]
27. Cyclic Cell-Penetrating Peptides as Efficient Intracellular Drug Delivery Tools.
Park SE; Sajid MI; Parang K; Tiwari RK
Mol Pharm; 2019 Sep; 16(9):3727-3743. PubMed ID: 31329448
[TBL] [Abstract][Full Text] [Related]
28. Click-Free Synthesis of a Multivalent Tricyclic Peptide as a Molecular Transporter.
Kumar S; Mandal D; El-Mowafi SA; Mozaffari S; Tiwari RK; Parang K
Pharmaceutics; 2020 Sep; 12(9):. PubMed ID: 32899170
[TBL] [Abstract][Full Text] [Related]
29. Plasmid DNA delivery using fluorescein-labeled arginine-rich peptides.
Oba M; Demizu Y; Yamashita H; Kurihara M; Tanaka M
Bioorg Med Chem; 2015 Aug; 23(15):4911-4918. PubMed ID: 26048025
[TBL] [Abstract][Full Text] [Related]
30. How to evaluate the cellular uptake of CPPs with fluorescence techniques: Dissecting methodological pitfalls associated to tryptophan-rich peptides.
Seisel Q; Pelletier F; Deshayes S; Boisguerin P
Biochim Biophys Acta Biomembr; 2019 Sep; 1861(9):1533-1545. PubMed ID: 31283917
[TBL] [Abstract][Full Text] [Related]
31. Cyclic Peptide Containing Hydrophobic and Positively Charged Residues as a Drug Delivery System for Curcumin.
Shirazi AN; El-Sayed NS; Tiwari RK; Tavakoli K; Parang K
Curr Drug Deliv; 2016; 13(3):409-17. PubMed ID: 26511089
[TBL] [Abstract][Full Text] [Related]
32. Cyclic peptide-capped gold nanoparticles as drug delivery systems.
Nasrolahi Shirazi A; Mandal D; Tiwari RK; Guo L; Lu W; Parang K
Mol Pharm; 2013 Feb; 10(2):500-11. PubMed ID: 22998473
[TBL] [Abstract][Full Text] [Related]
33. Comparison of cationic and amphipathic cell penetrating peptides for siRNA delivery and efficacy.
Mo RH; Zaro JL; Shen WC
Mol Pharm; 2012 Feb; 9(2):299-309. PubMed ID: 22171592
[TBL] [Abstract][Full Text] [Related]
34. Amphiphilic Cell-Penetrating Peptides Containing Arginine and Hydrophobic Residues as Protein Delivery Agents.
Moreno J; Zoghebi K; Salehi D; Kim L; Shoushtari SK; Tiwari RK; Parang K
Pharmaceuticals (Basel); 2023 Mar; 16(3):. PubMed ID: 36986567
[TBL] [Abstract][Full Text] [Related]
35. Effects of cargo molecules on the cellular uptake of arginine-rich cell-penetrating peptides.
Maiolo JR; Ferrer M; Ottinger EA
Biochim Biophys Acta; 2005 Jun; 1712(2):161-72. PubMed ID: 15935328
[TBL] [Abstract][Full Text] [Related]
36. The stoichiometry of peptide-heparan sulfate binding as a determinant of uptake efficiency of cell-penetrating peptides.
Wallbrecher R; Verdurmen WP; Schmidt S; Bovee-Geurts PH; Broecker F; Reinhardt A; van Kuppevelt TH; Seeberger PH; Brock R
Cell Mol Life Sci; 2014 Jul; 71(14):2717-29. PubMed ID: 24270856
[TBL] [Abstract][Full Text] [Related]
37. Characterisation of cell-penetrating peptide-mediated peptide delivery.
Jones SW; Christison R; Bundell K; Voyce CJ; Brockbank SM; Newham P; Lindsay MA
Br J Pharmacol; 2005 Aug; 145(8):1093-102. PubMed ID: 15937518
[TBL] [Abstract][Full Text] [Related]
38. Backbone rigidity and static presentation of guanidinium groups increases cellular uptake of arginine-rich cell-penetrating peptides.
Lättig-Tünnemann G; Prinz M; Hoffmann D; Behlke J; Palm-Apergi C; Morano I; Herce HD; Cardoso MC
Nat Commun; 2011 Aug; 2():453. PubMed ID: 21878907
[TBL] [Abstract][Full Text] [Related]
39. Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides.
Nakase I; Akita H; Kogure K; Gräslund A; Langel U; Harashima H; Futaki S
Acc Chem Res; 2012 Jul; 45(7):1132-9. PubMed ID: 22208383
[TBL] [Abstract][Full Text] [Related]
40. The use of electronic-neutral penetrating peptides cyclosporin A to deliver pro-apoptotic peptide: A possibly better choice than positively charged TAT.
Gao W; Yang X; Lin Z; He B; Mei D; Wang D; Zhang H; Zhang H; Dai W; Wang X; Zhang Q
J Control Release; 2017 Sep; 261():174-186. PubMed ID: 28662902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
